123 related articles for article (PubMed ID: 12809843)
1. Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practice.
Shiffman ML; Ferreira-Gonzalez A; Reddy KR; Sterling RK; Luketic VA; Stravitz RT; Sanyal AJ; Garrett CT; De Medina M; Schiff ER
Am J Gastroenterol; 2003 May; 98(5):1159-66. PubMed ID: 12809843
[TBL] [Abstract][Full Text] [Related]
2. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
3. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
[TBL] [Abstract][Full Text] [Related]
4. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.
Desombere I; Van Vlierberghe H; Couvent S; Clinckspoor F; Leroux-Roels G
J Clin Microbiol; 2005 Jun; 43(6):2590-7. PubMed ID: 15956369
[TBL] [Abstract][Full Text] [Related]
5. Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays.
Sarrazin C; Teuber G; Kokka R; Rabenau H; Zeuzem S
Hepatology; 2000 Oct; 32(4 Pt 1):818-23. PubMed ID: 11003628
[TBL] [Abstract][Full Text] [Related]
6. Effect of genotypes on the quantification of hepatitis C virus (HCV) RNA in clinical samples using the Amplicor HCV Monitor Test and the Quantiplex HCV RNA 2.0 assay (bDNA).
Tong CY; Hollingsworth RC; Williams H; Irving WL; Gilmore IT
J Med Virol; 1998 Jul; 55(3):191-6. PubMed ID: 9624605
[TBL] [Abstract][Full Text] [Related]
7. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
[TBL] [Abstract][Full Text] [Related]
8. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C.
Radkowski M; Gallegos-Orozco JF; Jablonska J; Colby TV; Walewska-Zielecka B; Kubicka J; Wilkinson J; Adair D; Rakela J; Laskus T
Hepatology; 2005 Jan; 41(1):106-14. PubMed ID: 15619235
[TBL] [Abstract][Full Text] [Related]
9. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J
Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
Kawai S; Yokosuka O; Imazeki F; Saisho H; Mizuno C
J Med Virol; 2002 Nov; 68(3):343-51. PubMed ID: 12226820
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
12. Standardization of hepatitis C virus RNA quantification.
Pawlotsky JM; Bouvier-Alias M; Hezode C; Darthuy F; Remire J; Dhumeaux D
Hepatology; 2000 Sep; 32(3):654-9. PubMed ID: 10960464
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays.
Lunel F; Cresta P; Vitour D; Payan C; Dumont B; Frangeul L; Reboul D; Brault C; Piette JC; Huraux JM
Hepatology; 1999 Feb; 29(2):528-35. PubMed ID: 9918931
[TBL] [Abstract][Full Text] [Related]
14. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
15. TaqMan amplification system with an internal positive control for HCV RNA quantitation.
Castelain S; Descamps V; Thibault V; François C; Bonte D; Morel V; Izopet J; Capron D; Zawadzki P; Duverlie G
J Clin Virol; 2004 Nov; 31(3):227-34. PubMed ID: 15465417
[TBL] [Abstract][Full Text] [Related]
16. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
[TBL] [Abstract][Full Text] [Related]
18. A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy.
Annicchiarico BE; Siciliano M; Avolio AW; Grillo RL; Bombardieri G
Aliment Pharmacol Ther; 2007 May; 25(9):1039-46. PubMed ID: 17439504
[TBL] [Abstract][Full Text] [Related]
19. Ribavirin in the treatment of hepatitis C.
Abonyi ME; Lakatos PL
Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
[TBL] [Abstract][Full Text] [Related]
20. Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment.
Comanor L; Anderson F; Ghany M; Perrillo R; Heathcote EJ; Sherlock C; Zitron I; Hendricks D; Gordon SC
Am J Gastroenterol; 2001 Oct; 96(10):2968-72. PubMed ID: 11693334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
